These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 24025056)

  • 1. Disorders of consciousness and pharmaceuticals that act on oxygen based amino acid and monoamine neurotransmitter pathways of the brain.
    Clauss R
    Curr Pharm Des; 2014; 20(26):4140-53. PubMed ID: 24025056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotransmitters in coma, vegetative and minimally conscious states, pharmacological interventions.
    Clauss RP
    Med Hypotheses; 2010 Sep; 75(3):287-90. PubMed ID: 20347531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotransmitters in disorders of consciousness and brain damage.
    Clauss RP
    Med Hypotheses; 2011 Aug; 77(2):209-13. PubMed ID: 21549512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacotherapy for disorders of consciousness: are 'awakening' drugs really a possibility?
    Ciurleo R; Bramanti P; Calabrò RS
    Drugs; 2013 Nov; 73(17):1849-62. PubMed ID: 24170667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of mexidol on the level of monoamine mediators and amino acids in rat brain structures].
    Miroshnichenko II; Smirnov LD; Voronin AE; Kuz'mina SIu; Veretennikov NA; Burov IuV
    Biull Eksp Biol Med; 1996 Feb; 121(2):170-3. PubMed ID: 9026123
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of phenibut on the content of monoamines, their metabolites, and neurotransmitter amino acids in rat brain structures].
    Borodkina LE; Kudrin VS; Klodt PM; Narkevich VB; Tiurenkov IN
    Eksp Klin Farmakol; 2009; 72(1):60-3. PubMed ID: 19334514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoamine modulation of tonic GABAA inhibition.
    Crunelli V; Di Giovanni G
    Rev Neurosci; 2014; 25(2):195-206. PubMed ID: 24468610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The monoamine neurotransmitter disorders: an expanding range of neurological syndromes.
    Kurian MA; Gissen P; Smith M; Heales S; Clayton PT
    Lancet Neurol; 2011 Aug; 10(8):721-33. PubMed ID: 21777827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effect of post-ischemic hypothermia duration on cerebral ischemic injury.
    Zhang H; Zhou M; Zhang J; Mei Y; Sun S; Tong E
    Neurol Res; 2008 May; 30(4):332-6. PubMed ID: 18544246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoamine neurotransmitter disorders--clinical advances and future perspectives.
    Ng J; Papandreou A; Heales SJ; Kurian MA
    Nat Rev Neurol; 2015 Oct; 11(10):567-84. PubMed ID: 26392380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The use of L-tryptophan for correction of disbalance of central neurotransmitters in morphine withdrawal syndrome].
    Razvodovskiĭ IuE; Doroshenko EM; Selevich MI
    Eksp Klin Farmakol; 2003; 66(1):12-6. PubMed ID: 12683073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercise and brain neurotransmission.
    Meeusen R; De Meirleir K
    Sports Med; 1995 Sep; 20(3):160-88. PubMed ID: 8571000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric neurotransmitter diseases.
    Pearl PL; Wallis DD; Gibson KM
    Curr Neurol Neurosci Rep; 2004 Mar; 4(2):147-52. PubMed ID: 14984687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain monoamines in hepatic encephalopathy and other types of metabolic coma.
    Jellinger K; Riederer P; Rausch WD; Kothbauer P
    J Neural Transm Suppl; 1978; (14):103-20. PubMed ID: 39973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amantadine, apomorphine and zolpidem in the treatment of disorders of consciousness.
    Gosseries O; Charland-Verville V; Thonnard M; Bodart O; Laureys S; Demertzi A
    Curr Pharm Des; 2014; 20(26):4167-84. PubMed ID: 24025057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenge tests of monoaminergic systems: neurophysiological aspects.
    Norra C
    Clin EEG Neurosci; 2007 Apr; 38(2):66-73. PubMed ID: 17515170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neurochemical study of effects of the new anxiolytic drugs afobazol and ladasten on the synthesis and metabolism of monoamines and their metabolites in the brain structures of Wistar rat on the model of monoamine synthesis blockade induced by aromatic amino acid decarboxylase inhibitor NSD-1015].
    Davydova AI; Klodt PM; Kudrin VS; Kuznetsova EA; Narkevich VB
    Eksp Klin Farmakol; 2010 Mar; 73(3):2-6. PubMed ID: 20408420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurochemical changes after imbalanced diets suggest a brain circuit mediating anorectic responses to amino acid deficiency in rats.
    Gietzen DW; Erecius LF; Rogers QR
    J Nutr; 1998 Apr; 128(4):771-81. PubMed ID: 9521642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Research traditional Chinese medicine properties by detecting rats' monoamine neurotransmitter after given two different traditional Chinese medicine].
    Li J; Zhang D; Zhang X; Wang X; Zeng S
    Zhongguo Zhong Yao Za Zhi; 2010 Apr; 35(8):1022-4. PubMed ID: 20617685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in turtle brain neurotransmitters and related substances during anoxia.
    Nilsson GE; Alfaro AA; Lutz PL
    Am J Physiol; 1990 Aug; 259(2 Pt 2):R376-84. PubMed ID: 1696793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.